Contract 75D30123P16354
University Of Massachusetts Biologic Labs · Department Of Health And Human Services · June 9, 2023
University Of Massachusetts Biologic Labs was awarded a federal contract by Department Of Health And Human Services (Centers For Disease Control And Prevention) on June 9, 2023 for $125,000 (current value) of work in pharmaceutical preparation manufacturing. Performance is in Atlanta, GA. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on April 10, 2024. If all options are exercised, the contract could reach $125,000.
Contract details
- PIID
- 75D30123P16354
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Medical- Other
- Place of performance
- Atlanta, GA
- First action
- June 9, 2023
- Latest action
- April 10, 2024
Description
25 DOSES OF EDAT 160,000IU
Modification timeline
-
April 10, 2024Mod P00001$-125.0K
-
June 9, 2023Base award$125.0K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Four Points Technology, L.L.C. | Department Of Health And Human Services | March 31, 2026 | $246.6K |
| Astrazeneca Pharmaceuticals Lp | Department Of Health And Human Services | March 31, 2026 | $122.8K |
| Ase Direct, Inc. | Department Of Health And Human Services | March 30, 2026 | $49.0K |
| Mckesson Corporation | Department Of Health And Human Services | March 30, 2026 | $9.00M |
| Emergent Biosolutions Canada Inc | Department Of Health And Human Services | March 30, 2026 | $256.40M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 27, 2026 | $92.33M |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75D30123P16354?
Contract 75D30123P16354 is a federal contract awarded to University Of Massachusetts Biologic Labs by Department Of Health And Human Services on June 9, 2023 for $125,000 of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 1 time since the base award.
Who won contract 75D30123P16354?
University Of Massachusetts Biologic Labs won contract 75D30123P16354 from Department Of Health And Human Services.
How much is contract 75D30123P16354 worth?
Contract 75D30123P16354 has obligated $0 to date but carries a potential ceiling of $125,000 if fully funded and all options are exercised.